Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Carcinoma, Non-Small-Cell Lung"
topic_facet:"Phase: Phase 1, Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=10
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=10
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle&page=10
PubPharm (300)
91
Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab : A Phase 1b/2a Pilot Study to Evaluate the Safety and Tolerability of Autologous T-Cells Expressing Enhanced TCRs (T Cell Receptors) Specific for NY-ESO-1/LAGE-1a (GSK3377794) Alone, or in Combination With Pembrolizumab in HLA-A2+ Participants With NY-ESO-1- or LAGE-1a-Positive Advanced or Recurrent Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
92
Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer : Phase I/II Trial of Image-Guided, Intensity-Modulated Photon (IMRT) or Scanning Beam Proton Therapy (IMPT) Both With Simultaneous Integrated Boost (SIB) Dose Escalation to the Gross Tumor Volume (GTV) With Concurrent Chemotherapy for Stage II/III Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
93
SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects : Stereotactic Body Radiotherapy Radiotherapy With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
94
Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer : Phase I/II Trial of MK-3475 and Hypofractionated Stereotactic Radiation Therapy in Patients With NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
95
Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced : A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer - (IM-BATTLE-2 Program)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
96
A Beta-only IL-2 ImmunoTherapY Study : A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
97
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) : A Phase I/II Study of Pembrolizumab and Vorinostat in Patients With Immune Therapy Naïve and Immune Therapy Pretreated Stage IV NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
98
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies : An Open-label, Single-Center, Phase 1b/2 Study to Evaluate the Safety of Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Malignancies After Progression on PD-1 or PD-L1 Targeted Antibodies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
99
Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %. : Phase Ib/II Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
100
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation : KontRASt-03: A Phase Ib/II, Multicenter, Open-label Platform Study of JDQ443 With Select Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
5
6
7
8
9
10
11
12
13
14
15
Nächster »
[30]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Carcinoma, Non-Small-Cell Lung
Filter aufheben
Thema: Phase: Phase 1, Phase 2
Medienart
300
Aufsätze
300
E-Artikel
300
E-Ressourcen
Zeitschriftentitel
300
ClinicalTrials.gov
Thema
300
610
Carcinoma, Non-Small-Cell Lung
Phase: Phase 1, Phase 2
300
Study Type: Interventional
187
Lung Neoplasms
146
Recruitment Status: Recruiting
48
Carcinoma
47
Recruitment Status: Completed
43
Recruitment Status: Active, not recruiting
36
Neoplasms
35
Recruitment Status: Terminated
24
Colorectal Neoplasms
22
Recruitment Status: Not yet recruiting
18
Melanoma
12
Carcinoma, Renal Cell
12
Triple Negative Breast Neoplasms
11
Breast Neoplasms
11
Ovarian Neoplasms
10
Mesothelioma
10
Squamous Cell Carcinoma of Head and Neck
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
125
2024
115
2023
45
2022
15
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
300
Englisch
Haven't found what you're looking for?
Wird geladen...